0.07
+0.0091(+13.87%)
Currency In USD
| Previous Close | 0.07 |
| Open | 0.06 |
| Day High | 0.08 |
| Day Low | 0.06 |
| 52-Week High | 5.44 |
| 52-Week Low | 0.06 |
| Volume | 18.34M |
| Average Volume | 25.72M |
| Market Cap | 8.95M |
| PE | -0.32 |
| EPS | -0.23 |
| Moving Average 50 Days | 0.1 |
| Moving Average 200 Days | 1.23 |
| Change | 0.01 |
If you invested $1000 in Conduit Pharmaceuticals Inc. (CDT) since IPO date, it would be worth $7.52 as of December 21, 2024 at a share price of $0.075. Whereas If you bought $1000 worth of Conduit Pharmaceuticals Inc. (CDT) shares 1 year ago, it would be worth $14.94 as of December 21, 2024 at a share price of $0.075.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
GlobeNewswire Inc.
Dec 12, 2024 12:30 PM GMT
Conduit Pharmaceuticals partners with SARBORG Limited to leverage artificial intelligence and cybernetics for optimizing key drug development processes, including drug repurposing, discovery, and clinical trial monitoring. This innovative approach ai
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
GlobeNewswire Inc.
Nov 21, 2024 12:30 PM GMT
Approval of composition of matter patent in key jurisdiction underscores the Company’s commitment to maximize future out-licensing valueNAPLES, Fla. and CAMBRIDGE, United Kingdom, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasd
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
GlobeNewswire Inc.
Nov 19, 2024 9:30 PM GMT
Conduit Pharmaceuticals strengthens its Board of Directors with the addition of Simon Fry, a seasoned investment banking executive with over 30 years of experience in asset management, capital markets, and strategy development. NAPLES, Fla. and CAMBR